The Notch1 gene may control cell chemoresistance in esophageal squamous cell cancer

Kun Gao1, Wenqun Xing1, Xianben Liu1

  • 1Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.

Abstract

Insights

Missense mutations in the Notch1 gene enhance Notch1-DLL4 interactions by increasing water-bridge bonds. This may increase pathway activation in chemotherapy-resistant esophageal squamous cell cancer (ESCC).

Area of Science:

  • Molecular biology
  • Cancer research
  • Bioinformatics

Background:

  • Previous studies identified missense mutations in the Notch1 gene in chemotherapy-resistant esophageal squamous cell cancer (ESCC).
  • This study investigates how these missense mutations alter the interaction between Notch1 and its ligand DLL4.

Purpose of the Study:

  • To explore the structural and functional consequences of Notch1 missense mutations on Notch1-DLL4 interactions.
  • To understand the potential impact of these altered interactions on pathway activation in ESCC.

Main Methods:

  • Utilized bioinformatics and in silico modeling, including homology modeling (Swiss-Model) and site-directed mutation analysis (PyMOL).
  • Constructed Notch1-DLL4 ligand-receptor complex models and analyzed noncovalent interactions using PLIP.
  • Assessed structural and functional changes between wild-type (WT) and mutation-type (MT) Notch1 sequences.

Main Results:

  • The mutation site was identified within the Notch1-DLL4 binding region.
  • In silico modeling revealed that mutations alter surface charge and increase water-bridge bonds between Notch1 and DLL4 from 5 to 7.
  • These changes suggest an enhanced interaction between Notch1 and DLL4.

Conclusions:

  • Notch1 missense mutations increase water-bridge bonds, strengthening the Notch1-DLL4 interaction.
  • Enhanced binding may lead to increased or prolonged activation of the Notch signaling pathway.
  • This mechanism could contribute to chemotherapy resistance in ESCC.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
280